BIOMANUFACTURING FEATURED ARTICLES

Implementing Single-Use At Bioprocessing’s Core
Implementing Single-Use At Bioprocessing’s Core

Expansions and renovations to existing biological facilities, and construction of new facilities, provide a unique opportunity to rethink basic design strategies and use new technologies to build a better facility that will improve compliance. One of the biggest drivers in the current evolution of biological facility design is the implementation of single-use systems (SUS).

  • How Can You Mitigate The Risks Of Single-Use Bags?
    How Can You Mitigate The Risks Of Single-Use Bags?

    The loss of product as a result of bag failure isn’t just an annoyance; it’s an expense, and a costly one at that. However, Chuck Hart, director of manufacturing at Prolong Pharmaceuticals, says with proper fitting and handling, these concerns can be mitigated.

  • Making The Switch To Single-Use: Have You Thought Of Everything?
    Making The Switch To Single-Use: Have You Thought Of Everything?

    In 2014, Prolong Pharmaceuticals followed through with a decision to build a facility for the scale-up of their lead product, SANGUINATE. As part of this decision, the new facility would not utilize Prolong’s traditional manufacturing process and would instead switch to one that uses single-use technology (SUT) almost exclusively. Chuck Hart, Prolong’s director of manufacturing, recently sat down with me to discuss some areas he feels are sometimes overlooked when switching from traditional stainless steel to SUT.

  • Is Sustainability Possible With Single-Use Technology?
    Is Sustainability Possible With Single-Use Technology?

    At this point, it is well known that single-use technology (SUT) can offer many benefits to a manufacturer and their facility. However, there are concerns that single-use technology produces too much harmful waste to achieve sustainability. But is this true?

More Featured Articles

BIOMANUFACTURING WHITE PAPERS & CASE STUDIES

  • Animal Component-Free, Fast-Attaching Microcarriers For Mammalian Cell Culture
    Animal Component-Free, Fast-Attaching Microcarriers For Mammalian Cell Culture

    With the continuing move of the biopharmaceutical and cell therapy industries toward the use of animal component- free materials in biomanufacturing processes, Pall Life Sciences has added a new, animal component-free microcarrier to its already extensive portfolio. Introducing Star-Plus, a rigid, spherical, low density microcarrier, featuring a proprietary chemistry built on the SoloHill® polystyrene core resulting in one of the fastest-attaching microcarriers available for many cell types under a variety of environmental conditions.

  • Can We Win The War Against Mycoplasma Contamination?
    Can We Win The War Against Mycoplasma Contamination?

    Mycoplasma maybe the smallest class of free living microorganism, but the consequences of a contamination in a cell batch during bioprocessing can be huge.

  • Automated Dual Feeding Into Recently Converted Bioreactors
    Automated Dual Feeding Into Recently Converted Bioreactors

    This case study explains how Parker Domnick Hunter (a division of Parker Hannifin) helped a pharmaceutical company optimize cell density in cell culture tanks that needed to be converted into fermenters to grow E. coli bacteria.

  • Private Branding: How On-Demand Color Labeling Can Add Value To The Growing Generics Market
    Private Branding: How On-Demand Color Labeling Can Add Value To The Growing Generics Market

    The generics market has taken off in recent years due to numerous patent expirations for brand-name companies. In light of this, pharmaceutical manufacturers, insurance companies and consumers, in search of significant cost savings, have turned towards the generics industry.

  • Adaption Of The BioLector Technology To Anaerobic Requirements
    Adaption Of The BioLector Technology To Anaerobic Requirements

    Biorefineries have reignited interest in anaerobic fermentations with biobutanol production being the principle driver. Already during the First World War Biobutanol and acetone were produced in Clostridium acetobutylicum.

  • Despite An Airport Strike, Marken Preserves The Data Chain
    Despite An Airport Strike, Marken Preserves The Data Chain

    Marken collected a shipment from southern Sweden that was bound for next-day delivery in northern Belgium. However, all airline flights into Belgium were cancelled as a result of a strike action by airport workers.

More White Papers & Case Studies

BIOMANUFACTURING PRODUCTS

Pharmaceutical Packaging and Barcode Inspection Software Pharmaceutical Packaging and Barcode Inspection Software

GlobalVision inspects barcodes directly in the software, so you don’t need to verify them with a device. It’s barcode checking and barcode validation made easy.

Single-Use Vessels For Cell Culture: BioBLU® c And BioBLU p Single-Use Vessels For Cell Culture: BioBLU® c And BioBLU p

Combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless steel bioreactors – Discover the Eppendorf BioBLU product line.

One Film For Your Entire Upstream Production: CX5-14 One Film For Your Entire Upstream Production: CX5-14

Thermo Scientific CX5-14 film is engineered to meet the most demanding requirements of your bioproduction processes.

Single-use Clarification Systems: Sartoclear Dynamics® Single-use Clarification Systems: Sartoclear Dynamics®

Sartoclear Dynamics® is a new single-use technology for harvesting animal cell cultures with high cell densities. Consistent results, ease of use, enormous speed and flexible scalability are the key characteristics of this technology.

HyPerforma™ Single-Use Fermentor (S.U.F.) HyPerforma™ Single-Use Fermentor (S.U.F.)

The S.U.F. is engineered for optimal oxygen mass transfer, mixing, and temperature control, and performs comparably to traditional stainless steel systems. Using traditional, fundamental engineering principles, scale-up and process development work is streamlined – offering you cost savings and efficiency. 
 

HyClone Cell Culture Media, Sera And Process Liquids HyClone Cell Culture Media, Sera And Process Liquids

In March 2014, GE Healthcare Life Sciences announced the completion of the acquisition of the HyClone cell culture media business  from Thermo Fisher Scientific.  The addition of the HyClone portfolio significantly broadens our existing capabilities in life sciences research and bioprocessing. The result is a comprehensive portfolio of products and services across the whole biomanufacturing workflow, from upstream to downstream, from discovery to commercialization.

More Products

BIOMANUFACTURING MEDIA

Global Advantage: Free Trade Zones In China Global Advantage: Free Trade Zones In China

Learn more about how free trade zones can offer cost-efficient ways to manage your clinical trial.

Demand Led Services and Clinical Supply Efficiency Demand Led Services and Clinical Supply Efficiency

See how this service can benefit you with shorter lead time, less waste, less stock out risk and no booklet labels.

Creating A New Synergy Between Single-Use Adopters And Suppliers Creating A New Synergy Between Single-Use Adopters And Suppliers

In this webinar Celia Landers from MilliporeSigma discusses finding the optimal path to balance single-use lead times with design flexibility and supply predictability. 

More Media

BIOMANUFACTURING INDUSTRY NEWS

More Industry News